A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.
Patients with greater frailty showed larger improvements in health-related quality of life, while cardiovascular treatment effects did not differ significantly across frailty categories.
Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.
Estrogen-based therapy is now recommended first for vasomotor symptoms, with SNRIs, SSRIs, gabapentin, and neurokinin receptor antagonists reserved for later lines.
A healthy lifestyle was associated with a smaller loss of disease-free life expectancy related to social isolation, but the same pattern did not hold for loneliness.